Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solventum Corporation Common Stock (NY:SOLV)

89.81 -0.57 (-0.63%)
Delayed Quote Updated: 12:21 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Solventum Q3 Earnings Call Highlights ↗
Solventum (NYSE:SOLV) raised its 2026 earnings outlook after reporting third-quarter results that exceeded its expectations for organic growth and earnings, even as the reversal of advance orders... 
Via MarketBeat
Topics ETFs Earnings
News headline image
Solventum (SOLV) stock trades up, here is why
What happened? Shares of healthcare solutions provider Solventum (NYSE:SOLV) jumped 5% in the afternoon session after the company reported third-quarter 2026... 
Via StockStory
Topics Economy Initial Public Offering Stocks
S&P 500 Unusual Volume Movers for Nov. 6, 2026 ↗
Via Chartmill
Topics Stocks
News headline image
Solventum (SOLV) Q3 2026 Earnings Call Transcript ↗
Solventum's ERP cutover is done, but a margin hit from the HIS spin looms. 
Via The Motley Fool
Topics Earnings World Trade
Solventum (NYSE:SOLV) Q3 2026 Earnings: In-Line Revenue, EPS Beat, Shares Flat After Hours ↗
Via Chartmill
Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds ↗
Via Chartmill
News headline image
SOLV Q3 2026 deep dive: ERP transition, separation milestones, and margin focus define quarter
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 2026 results topping the market’s revenue expectations, but sales fell by 7% year on year to ... 
Via StockStory
Topics World Trade
News headline image
Solventum (NYSE:SOLV) beats Q3 2026 sales expectations
Healthcare solutions provider Solventum (NYSE:SOLV) announced better-than-expected revenue in Q3 2026, but revenue fell by 7% year on year to $1.95 billion. ... 
Via StockStory
S&P 500 After-Hours Movers: ABNB and SNDK Gain, AXON and SOLV Fall ↗
Via Chartmill
Topics Stocks
News headline image
Solventum (SOLV) Q3 earnings report preview: what to look for
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting earnings this Thursday after the bell. Here’s what investors should know. Solventum bea... 
Via StockStory
News headline image
2 cash-burning stocks for long-term investors and 1 we turn down
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sh... 
Via StockStory
Topics Credit Cards
News headline image
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
From Wall Street Investor
Via GlobeNewswire
News headline image
3 Overrated Stocks We Approach with Caution
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NY... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
2 Profitable Stocks for Long-Term Investors and 1 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
Due Diligence Check: Do These "Blue Chips" Still Earn the Title? ↗
"Blue chip" gets applied to a company once and tends to stick, regardless of what the balance sheet does afterward. The label describes reputation, not cur 
Via Talk Markets
News headline image
Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 S&P 500 Stocks with Open Questions
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
Topics Energy
News headline image
3 Value Stocks with Open Questions
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
3 Reasons to Avoid SOLV and 1 Stock to Buy Instead
Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due t... 
Via StockStory
Topics Stocks
News headline image
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
Solventum (SOLV) Q2 2026 Earnings Call Transcript ↗
CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
News Provided by USA News Group on behalf of Conexeu Sciences Inc. 
From USA News Group
Via GlobeNewswire
News headline image
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Solventum Q2 Earnings Call Highlights ↗
Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff... 
Via MarketBeat
Topics ETFs Earnings World Trade
News headline image
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.... 
Via StockStory
News headline image
Solventum Nears Inflection Point As It Begins to Unlock Value ↗
Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers. 
Via MarketBeat
Topics Initial Public Offering
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to ... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.